BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6803286)

  • 1. Effects of apomorphine and piribedil on pentylenetetrazol-induced seizures in mice.
    Riffee WH; Wilcox RE; Goldman CP; Smith RV
    Psychopharmacology (Berl); 1981; 75(4):391-5. PubMed ID: 6803286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ascorbate on a dopaminergic response: apomorphine-induced modification of pentylenetetrazol-induced seizures in mice.
    Wilcox RE; Riffee WH; Goldman CP; Young RK
    Psychopharmacology (Berl); 1984; 83(1):48-50. PubMed ID: 6429699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of apomorphine, ergocornine and piribedil on audiogenic seizures in DBA/2 mice.
    Anlezark GM; Meldrum BS
    Br J Pharmacol; 1975 Mar; 53(3):419-21. PubMed ID: 1173346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the locomotor activity effects of apomorphine and the "atypical dopamine agonists" (piribedil and S3608).
    Offermeier J; van Rooyen JM
    Life Sci; 1986 Mar; 38(10):895-903. PubMed ID: 3081774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive changes in the effects of angiotensin II on the convulsive-seizure threshold in cases of altered sensitivity of dopamine receptors.
    Georgiev V; Petkova B; Kambourova T
    Methods Find Exp Clin Pharmacol; 1988 May; 10(5):295-9. PubMed ID: 3398646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain dopamine and seizure susceptibility in mice.
    Kleinrok Z; Czuczwar S; Wójcik A; Przegaliński E
    Pol J Pharmacol Pharm; 1978; 30(4):513-9. PubMed ID: 740553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yawning elicited by systemic and intrastriatal injection of piribedil and apomorphine in the rat.
    Dourish CT; Cooper SJ; Philips SR
    Psychopharmacology (Berl); 1985; 86(1-2):175-81. PubMed ID: 2991964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of piribedil on body temperature in mice and rats.
    Kapturkiewicz Z; Sowińska H
    Pol J Pharmacol Pharm; 1977; 29(6):609-18. PubMed ID: 600860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential actions of dopamine agonists and antagonists on the gamma-butyrolactone-induced in mouse brain dopamine.
    Gianutsos G; Thornburg JE; Moore KE
    Psychopharmacology (Berl); 1976 Nov; 50(3):225-9. PubMed ID: 826966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apomorphine and piribedil in rats: biochemical and pharmacologic studies.
    Butterworth RF; Poignant JC; Barbeau A
    Adv Neurol; 1975; 9():307-26. PubMed ID: 1170716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prejunctional actions of piribedil on the isolated kidney of the rabbit: comparison with apomorphine.
    Chevillard C; Mathieu MN; Recommis D
    Br J Pharmacol; 1980; 71(2):513-8. PubMed ID: 7470760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral interactions between naloxone and dopamine agonists.
    Harris RA; Snell D; Loh HH; Way EL
    Eur J Pharmacol; 1977 Jun; 43(3):243-6. PubMed ID: 872878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of dopamine agonists and haloperidol on release of prolactin, thyroid stimulating hormone, growth hormone and luteinizing hormone in rats.
    Mueller GP; Simpkins J; Meites J; Moore KE
    Neuroendocrinology; 1976; 20(2):121-35. PubMed ID: 958594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of dopamine, apomorphine and piribedil on the mesenterial blood flow of the cat.
    György L; Dóda M
    Arch Int Pharmacodyn Ther; 1985 May; 275(1):22-32. PubMed ID: 4026462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of responsiveness to dopaminergic agonists.
    Reinstein DK; McClearn D; Isaacson RL
    Brain Res; 1978 Jul; 150(1):216-23. PubMed ID: 566610
    [No Abstract]   [Full Text] [Related]  

  • 16. Action of neuroleptics and antidepressants on the hypothermia produced by dopaminomimetics apomorphine and piribedil in mice.
    Schelkunov EL
    J Neural Transm; 1980; 47(4):307-12. PubMed ID: 6104689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Femoral vasodilatation produced by piribedil (ET495) and its metabolite S584 in the hindleg of the dog.
    Buylaert WA
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Aug; 299(1):101-3. PubMed ID: 904692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
    Löscher W; Hönack D
    Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responses of central neurones to piribedil and 2-bromo-alpha-ergocryptine: comparison with dopamine and apomorphine.
    Bioulac B; Fumoux F; Ferron A; Vincent JD
    Eur J Pharmacol; 1978 Sep; 51(1):29-37. PubMed ID: 699972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a D1 and a D2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys.
    Woolverton WL
    Pharmacol Biochem Behav; 1986 Mar; 24(3):531-5. PubMed ID: 2871561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.